Biomarker Lens

Biomarkers · Chemical

Li-Fraumeni Syndrome, TP53 Sequencing and Deletion/Duplication

Understand what Li-Fraumeni Syndrome, TP53 Sequencing and Deletion/Duplication signals

LOINC codes
21739-8, 50398-7, 53037-8, 8266-9, 96970-9
Commercial laboratory assays
1

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for Li-Fraumeni Syndrome, TP53 Sequencing and Deletion/Duplication

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

Li-Fraumeni Syndrome, TP53 Sequencing and Deletion/Duplication

Laboratory
Quest Diagnostics
Test code
92560
Specimen
Blood
Fasting
Not stated
LOINC
21739-8, 50398-7, 53037-8, 8266-9, 96970-9
Turnaround
Set up: Tues, Thurs, Sat

Laboratory assay overview

Mutations in the TP53 gene leads to Li-Fraumeni Syndrome (LFS) which is an inherited cancer syndrome with an early onset of tumors, multiple tumors within an individual, and often multiple affected family members. The most common types of tumors are soft tissue sarcomas and osteosarcomas, breast cancer, brain tumors, leukemia, and adrenocortical carcinoma. Sequencing and deletion/duplication analyses of the TP53 gene will identify individuals who are affected with LFS and therefore at risk for TP53-related cancers.

View complete laboratory reference notes

See Laboratory Report

Quest Diagnostics test directory, test code 92560

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.